Document is current
Any future updates will be listed below
-
Authors
Fujishima, Yuki
Inaguma, Daijo
Kurasawa, Shimon
Okazaki, Masaki
Imaizumi, Takahiro
Maruyama, Shoichi https://orcid.org/0000-0002-8858-632X
-
Funding
Funding for this research was provided by:
Nagoya University
Nagoya University
- License Information
-
More Information
Article History
Received: 17 April 2025
Accepted: 9 September 2025
First Online: 29 October 2025
Declarations
:
: S. Kurasawa received honoraria from Kyowa Kirin Co., Ltd. (KKC) and Mochida Pharmaceutical Co., Ltd. T. Imaizumi received a grant and honoraria from KKC, and consulting fees from KKC and GlaxoSmithKline plc. All the remaining authors have nothing to disclose.
: AICOPP was registered at UMIN (study registration number UMIN000007096). All procedures conducted in studies involving human participants were under the ethical standards of the institutional and/or national research committee at which the studies were conducted (Nagoya University Hospital IRB approval number is 2019–0001) and with the 1964 Helsinki declaration and its later amendments.
: Informed consent was obtained from all individual participants included in the study.
